6^th Global Ophthalmologists Annual Meeting

Biography

Professor Ningli Wang is the Director of Beijing Tongren Eye Center and the vice president of Beijing Tongren Hospital, which is one of the two largest eye centers in China and provides a comprehensive and seamless Ophthalmic Service for 30,0000 outpatients and 54,000 surgeries annually. He is also the Director of Beijing Institute of Ophthalmology and the president of School of Ophthalmology, Capital Medical University. Prof. Wang is the President of Chinese Ophthalmology Society and also the President of Beijing Medical Association, Ophthalmology Society. Prof. Wang also serves as the Vice Chairman of Committee of China Medical Doctor Association. Prof. Wang is an active academician in Asian region. He is the Committee of Asia-Pacific Academy of Ophthalmology (APAO), the Committee of Asia-Africa Academy of Ophthalmology and the Executive Committee Member of World Glaucoma Association(WGA). Professor Ningli Wang has done many pioneering research works in Ophthalmology: 1. He proposed the new classification system of primary angle-closure glaucoma based on the mechanism of angle-closure; 2. He proposed the new theories that glaucoma may be caused be the high Trans-Lamina Cribrosa Pressure difference and conduct a series of studies to verify it; 3. He performed the study on the mechanism of glaucomatous posterior retinal neuron damage, and proposed the concept that glaucoma is a disorder of whole visual pathway; 4. He discovered the pathogenesis of exfoliation syndrome in Chinese population is different from that in European and American people, and made the diagnostic criteria of exfoliation syndrome for Chinese people; 5. He designed and spearheaded a number of new ophthalmic technologies, such as non-penetrating trabecular surgery, improved surgical extra-trabeculotomy, Schlemm's forming dilatation, two-phase aqueous drainage implantation and endoscopic implantation in high myopia etc; 6. He introduced the high-frequency ultrasound biomicroscopy and designed the ophthalmic panoramic ultrasound biomicroscopy with independent intellectual property rights; 7. He performed manufacturing technology and equipment research on implantable and individualized higher-order aberration corrective lens for human eyes by integrating innovation; 8. He organized some large-scale eye disease epidemiology in China - Handan Eye Study and An Yang Children Eye Study.Because of Prof. Wang’s academic accomplishment, he was awarded the second price of National Scientific Progress Award by the State Council in 2013 for his contribution in Primary Angle Closure Glaucoma (PACG), and won the first price twice in 2011 and in 2012 from Chinese Medical Association. And he was honored by Ministry of Health with Outstanding Contribution Expert Award. He was also honored by Chinese Medical Doctor Association for Medical Doctor Award in 2010. In 2011, Professor Wang received Arthur Lim Award in APAO; and he was also awarded with the Senior Clinician-Scientist by World Glaucoma Congress.

Research Interest

Glaucoma